Abstract
The modulation of immune system activity is a required pharmacological
intervention for many medical conditions, bearing particular importance in the
treatment of autoimmune diseases and allergies and transplant procedures. With
traditional immunomodulatory drugs continuing to exhibit limited efficacy and
adverse side effects, the drive to develop new, improved, and specifically
targeted immunotherapies has been gaining momentum. ' Immunomodulators:
Therapeutic Needs, Pipelines & Prospects' is a new report published by
Business Insights that provides a detailed examination of the current market
for immunomodulatory therapies. The strategies and technologies used in
immunomodulation are analysed and the major clinical applications of
immunomodulators are reviewed to identify the leading drug classes and most
promising agents currently in development. This report will also investigate
patient metrics and provide market forecasts for immunomodulators to 2011.
| 
View Cart
